Pulse Biosciences (PLSE) Return on Invested Capital (2022)

Pulse Biosciences (PLSE) recorded quarterly Return on Invested Capital of 0.04% in Q3 2022, down 59.89% quarter-over-quarter from 0.03% in Q2 2022.

Pulse Biosciences (PLSE) Return on Invested Capital (2022) Analysis & Trends

Pulse Biosciences' Return on Invested Capital history runs 1 years deep, the most recent figure standing at 0.04% for Q3 2022.

In Q3 2022, Return on Invested Capital changed N/A year-over-year to 0.04%; the TTM figure through Sep 2022 stood at 0.04% (changed N/A YoY), while the FY2015 annual figure was 0.0%, changed N/A from the prior year.
Return on Invested Capital was 0.04% for Q3 2022 at Pulse Biosciences, down from 0.03% in the prior quarter.
In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q1 2022 to a low of 0.04% in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	0.00%
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	0.00%
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	-
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	0.00%
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	0.00%
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	0.00%
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	0.00%
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	0.00%
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	0.00%
10	Pulse Biosciences	1.68 Bn	1.68 Bn	-	-

Download Data